Skip Navigation





Information on Clinical Trials at the University of Minnesota

Clinical trials, or clinical studies, take place in the clinic, a step after lab research studies. Clinical trials offer experimental treatments to patients that fit the criteria of a particular study and are used to determine whether new drugs or treatments are both safe and effective. There is some risk with any clinical trial, just as with many medical procedures; however, all clinical trials are reviewed by an Institutional Animal Care and Use Committee (IACUC) before they can begin. Also, informed owner consent is always part of clinical trials, so before your pet enters the study you will be given all information up front and must agree in writing. In many clinical trials, patients must be treated at the clinic conducting the trial and may not receive study drugs remotely.

The Clinical Investigation Center (CIC) facilitates veterinary clinical trials and translational research studies which may lead to new drugs, devices, procedures and treatments for the benefit of animals and humans alike. We do this by providing expertise, facilities, technical staff and overall study coordination.

For information about the CIC, click here.

For a description of and enrollment information about:

PRO-DOX: Clinical evaluation of propanolol in combination with doxorubicin for the treatment of hemangiosarcoma, click here.

Compassionate use of recombinant bispecific angiotoxin simultaneously targeting EGFR and uPAR (eBAT Comassionate Care), click here.

SRCBST2: dose-finding for a ligand targeted toxin to treat hemangiosarcoma: NO LONGER ENROLLING

Early Detection to Target Hemangiosarcoma Cells in Dogs: The Shine On Project: NEW ENROLLMENT IS ON HOLD. For information and updates on the project, click here.

VIGOR Trial: Translational approach for development of a novel oncolytic immunotherapy for osteosarcoma: NO LONGER ENROLLING. For information on the project, click here.